Significant Ownership of SAMLYN CAPITAL, LLC

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for SAMLYN CAPITAL, LLC focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager location
New York, NY
Manager signature
By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly* - Robert Pohly, Managing Member

Follow Filing Activity

Follow SAMLYN CAPITAL, LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of SAMLYN CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VINP Vinci Partners Investments Ltd. Class A Common Shares, par value US$0.00005 per share 4.8% $22,695,339 -$34,013 2,356,733 -0.15% SAMLYN CAPITAL, LLC 31 Mar 2025
PCT PureCycle Technologies, Inc. Common Stock, par value $0.001 per share 4.2% $48,960,458 -$35,642,845 7,896,848 -42% SAMLYN CAPITAL, LLC 31 Mar 2026
NKTR Nektar Therapeutics Common Stock, $0.0001 par value 0% $0 -$7,153,616 0 -100% SAMLYN CAPITAL, LLC 31 Mar 2025
CRVS Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 -$15,857,146 0 -100% SAMLYN CAPITAL, LLC 30 Jun 2025
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Samlyn Capital, LLC 31 Dec 2024

Schedules 13D/G Reported by SAMLYN CAPITAL, LLC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .